Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice
about
Lysophosphatidylinositol Signalling and Metabolic DiseasesHigh-fat diet-induced insulin resistance does not increase plasma anandamide levels or potentiate anandamide insulinotropic effect in isolated canine isletsThe therapeutic potential of orphan GPCRs, GPR35 and GPR55.Activation of GPR55 Receptors Exacerbates oxLDL-Induced Lipid Accumulation and Inflammatory Responses, while Reducing Cholesterol Efflux from Human Macrophages.The cannabinoid CB1 receptor and mTORC1 signalling pathways interact to modulate glucose homeostasis in mice.Human CB1 Receptor Isoforms, present in Hepatocytes and β-cells, are Involved in Regulating MetabolismG protein-coupled receptors: signalling and regulation by lipid agonists for improved glucose homoeostasis.Lysophosphatidylinositol-induced activation of the cation channel TRPV2 triggers glucagon-like peptide-1 secretion in enteroendocrine L cells.Advances in the Physiology of GPR55 in the Central Nervous System.Elevated cannabinoid receptor 1 and G protein-coupled receptor 55 expression in proximal tubule cells and whole kidney exposed to diabetic conditions.Evaluation of the insulin-releasing and glucose-lowering effects of GPR120 activation in pancreatic β-cells.Metabolic effects of orally administered small-molecule agonists of GPR55 and GPR119 in multiple low-dose streptozotocin-induced diabetic and incretin-receptor-knockout mice.Quercetin/oleic acid-based G-protein-coupled receptor 40 ligands as new insulin secretion modulators.Leptogenic effects of NAPE require activity of NAPE-hydrolyzing phospholipase D.LH-21 and abnormal cannabidiol improve β-cell function in isolated human and mouse islets through GPR55-dependent and -independent signalling.GPR55-dependent stimulation of insulin secretion from isolated mouse and human islets of Langerhans.Targeted proteomics of cannabinoid receptor CB1 and the CB1b isoform.
P2860
Q26771102-BDCA89F5-39DA-4EAE-8284-F0D98771EBC4Q35347646-FC521BFE-0216-484B-8DEB-8F2AF38FBB8BQ35425244-B3C36C94-45CA-4B12-AE52-A4DA3C834FC7Q35602343-5F04827E-1520-4367-B5C4-0022F496D99BQ35840211-142A3F72-4076-4B9C-B862-F551A007D438Q37264554-7BE00B46-FC2B-4D5C-BFDC-661258CED837Q38688833-1CA649F1-193F-4F41-8A88-C5119E994B38Q38702653-B51B16C6-1C3A-448F-86A8-5F602723E73AQ38917434-C1EF6E6B-3CE0-415E-9F9E-BD8612248DF5Q38924783-4F1CC01A-E91A-45DC-8251-0E03282EF923Q38985790-E9D94E72-C19C-4EE1-94B0-A1AB36C6A731Q39345729-B212E1EA-CFD5-4D28-B2E1-36EB5D20DD55Q47611209-A524E2A0-5290-45A2-A89D-E1260A6E0321Q47862279-3627DCB3-9CB6-4993-B775-AE3E05130BB1Q48178388-1DF7637B-58A1-45B4-B28B-C67D28BFFFE9Q51550177-8B975CF6-7BBB-492F-9F93-A2490EDE215DQ51735248-A79264A8-3450-4DB2-8963-2ED7C2E6651D
P2860
Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Evaluation of the insulin rele ...... ted pancreatic islets and mice
@en
Evaluation of the insulin rele ...... ed pancreatic islets and mice.
@nl
type
label
Evaluation of the insulin rele ...... ted pancreatic islets and mice
@en
Evaluation of the insulin rele ...... ed pancreatic islets and mice.
@nl
prefLabel
Evaluation of the insulin rele ...... ted pancreatic islets and mice
@en
Evaluation of the insulin rele ...... ed pancreatic islets and mice.
@nl
P2093
P2860
P356
P1476
Evaluation of the insulin rele ...... ted pancreatic islets and mice
@en
P2093
A M McKillop
Y H A Abdel-Wahab
P2860
P304
P356
10.1111/BPH.12356
P407
P577
2013-11-01T00:00:00Z